Gyre Therapeutics Inc GYRE
NASDAQ · United States · Health Technology
$7.33+0.01 (+0.14%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-07 | -0.12 | -0.06 | -111.8% | $29.11M | +9.9% | +5.0%$6.40→$6.72 |
| Q1 2026 | 2026-05-07 | -0.08 | -0.06 | -33.3% | — | — | -7.1%$8.04→$7.47 |
| Q4 2025 | 2026-03-12 | 0.05 | 0.01 | +400.0% | — | — | -9.2%$8.33→$7.56 |
| Q3 2025 | 2025-11-07 | 0.03 | -0.02 | +250.0% | — | — | +7.9%$7.34→$7.92 |
| Q2 2025 | 2025-08-11 | 0.00 | 0.03 | -100.0% | — | — | — |
| Q1 2025 | 2025-05-09 | 0.00 | 0.03 | -100.0% | — | — | — |
| Q4 2024 | 2025-03-17 | 0.00 | 0.04 | -100.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.